Back
Neurocrine Biosciences 10K Form
Sell
40
NBIX
Neurocrine Biosciences
Last Price:
$113.24
Seasonality Move:
6.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2023-10-31 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2023-08-01 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2023-05-03 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2022-11-01 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2022-08-04 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
Receive NBIX News And Ratings
See the #1 stock for the next 7 days that we like better than NBIX
NBIX Financial Statistics
Sales & Book Value
| Annual Sales: | $2.4B |
|---|---|
| Cash Flow: | $235.2M |
| Price / Cash Flow: | 21.05 |
| Annual Sales: | $26.05 |
| Price / Book: | 4.36 |
Profitability
| EPS (TTM): | 3.29000 |
|---|---|
| Net Income (TTM): | $341.3M |
| Gross Margin: | $2.3B |
| Return on Equity: | 13.72% |
| Return on Assets: | 9.87% |
Neurocrine Biosciences Earnings Forecast
Key Neurocrine Biosciences Financial Ratios
-
The Gross Profit Margin over the past 29 years for NBIX is 98.56%.
-
The Selling, General & Administrative Expenses for NBIX have been equal to 42.76% of Gross Profit Margin.
-
The Research & Development expenses have been 31.04% of Revenue.
-
The Interest Expense is 37.09% of Operating Income.
-
The Net Earning history of NBIX is 14.49% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 14 years.
Neurocrine Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NBIX |
| CUSIP: | 64125C |
| Website: | neurocrine.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.4 |
| Quick Ratio: | 3.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 34.4 |
|---|---|
| Forward P/E Ratio: | 12.65 |
NBIX Technical Analysis vs Fundamental Analysis
Sell
40
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a SellThe current Neurocrine Biosciences [NBIX] share price is $113.16. The Score for NBIX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.